Viatris (VTRS) Competitors

argenx (NASDAQ:ARGX) and Viatris (NASDAQ:VTRS) are both large-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their community ranking, risk, analyst recommendations, earnings, valuation, institutional ownership, dividends, media sentiment and profitability.

Is ARGX or VTRS more profitable?

argenx has a net margin of -2.11% compared to Viatris' net margin of -5.87%. Viatris' return on equity of 16.46% beat argenx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
argenx	-2.11%	-1.45%	-1.29%
Viatris	-5.87%	16.46%	7.09%

Which has higher valuation and earnings, ARGX or VTRS?

Viatris has higher revenue and earnings than argenx. Viatris is trading at a lower price-to-earnings ratio than argenx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
argenx	$2.58B	13.62	-$295.05M	$16.21	35.50
Viatris	$14.33B	0.74	$54.70M	-$3.17	-2.85

Which has more volatility & risk, ARGX or VTRS?

argenx has a beta of 0.39, suggesting that its stock price is 61% less volatile than the S&P 500. Comparatively, Viatris has a beta of 0.9, suggesting that its stock price is 10% less volatile than the S&P 500.

Does the MarketBeat Community believe in ARGX or VTRS?

argenx received 642 more outperform votes than Viatris when rated by MarketBeat users. Likewise, 67.58% of users gave argenx an outperform vote while only 34.33% of users gave Viatris an outperform vote.

Company	Underperform	Outperform
argenx	Outperform Votes 665 67.58%	Underperform Votes 319 32.42%
Viatris	Outperform Votes 23 34.33%	Underperform Votes 44 65.67%

Do analysts rate ARGX or VTRS?

argenx currently has a consensus price target of $709.18, indicating a potential upside of 23.24%. Viatris has a consensus price target of $10.40, indicating a potential upside of 15.04%. Given argenx's stronger consensus rating and higher possible upside, equities research analysts plainly believe argenx is more favorable than Viatris.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
argenx	0 Sell rating(s)	1 Hold rating(s)	19 Buy rating(s)	2 Strong Buy rating(s)	3.05
Viatris	2 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.80

Does the media favor ARGX or VTRS?

In the previous week, argenx had 1 more articles in the media than Viatris. MarketBeat recorded 8 mentions for argenx and 7 mentions for Viatris. argenx's average media sentiment score of 0.78 beat Viatris' score of 0.00 indicating that argenx is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
argenx	4 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Viatris	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral

Do insiders and institutionals have more ownership in ARGX or VTRS?

60.3% of argenx shares are owned by institutional investors. Comparatively, 79.9% of Viatris shares are owned by institutional investors. 2.4% of argenx shares are owned by insiders. Comparatively, 0.1% of Viatris shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

argenx beats Viatris on 12 of the 19 factors compared between the two stocks.